Cell adhesion molecules and colon cancer

Australian and New Zealand Journal of Surgery

Volumn 66, Issue 12, 1996, Pages 791-798

  Agrez, Michael V ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cell adhesion molecules; Colon cancer

Indexed keywords

CADHERIN; CARCINOEMBRYONIC ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; MUCIN;

CELL ADHESION; COLON CANCER; EXTRACELLULAR MATRIX; HUMAN; REVIEW;

EID: 0030443509     PISSN: 00048682     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.1996.tb00752.x     Document Type: Review

References (84)

1. Thorne RF, Meldrum CJ, Agrez MV. Adhesion molecules and metastasis. Life Sci. 1995; 7: 32-7.
2. Pignatelli M, Smith M, Bodmer W. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas. Br. J. Cancer 1990; 61: 636-8.
3. Koretz K, Fietz T, Laque M, Bruderlein S, Henne C, Moller P. Fibronectin and fibronectin-receptors of the integrin type in normal colon mucosa, adenomas and carcinoma. Int. J. Oncol. 1994; 5: 1315-23.
4. Stallmach A, v. Lampe B, Matthes H, Bornhoft G, Riecken E. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation. Gut 1992; 33: 342-6.
5. Varner JA, Emerson DA, Juliano RL. Integrin α5β1 expression negatively regulates cell growth: Reversal by attachment to fibronectin. Mol. Biol. Cell 1995; 6: 725-40.
6. Bates RC, Buret A, van Helden DF, Horton M, Burns GF. Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 1994; 125: 403-15.
7. Agrez M, Chen A, Cone RI, Pytela R, Sheppard D. The αvβ6 integrin promotes proliferation of colon carcinoma cells through a unique region of the β6 cytoplasmic domain. J. Cell Biol. 1994; 127: 547-56.
8. Dorudi S, Sheffield JP, Poulsom R, Northover JMA, Hart IR. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am. J. Pathol. 1993; 142: 981-6.
9. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-19.
10. Cunningham L, Stocking B, Halter SA, Kalemeris G. Immunoperoxidase staining of carcinoembryonic antigen as a prognostic indicator in colorectal carcinoma. Dis. Colon Rectum 1986; 29: 111-16.
11. Hashino J, Fukuda Y, Oikawa S, Nakazato H, Nakanishi T. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen. Clin. Exp. Metastasis 1994; 12: 324-8.
12. Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc. Natl. Acad. Sci. USA 1993; 90: 10744-8.
13. Wielenga VJM, Heider K-H, Offerhaus GJA et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 1993; 53: 4754-6.
14. Irimura T, Matsushita Y, Hoff SD et al. Ectopic expression of mucins in colorectal cancer metastasis. Semin. Cancer Biol. 1991; 2: 129-39.
15. Schwartz B, Bresalier RS, Kim YS. The role of mucin in colon-cancer metastasis. Int. J. Cancer 1992; 52: 60-5.
16. Hynes RO. Integrins: Versatility, modulation and signaling in cell adhesion. Cell 1992; 69: 11-25.
17. Palmer EL, Ruegg C, Ferrando R, Pytela R, Sheppard D. Sequence and tissue distribution of the α9 subunit, a novel partner of β1 that is widely distributed in epithelia and muscle. J. Cell Biol. 1993; 123: 1289-97.
18. Symington BE, Takada Y, Carter WG. Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: Potential role in keratinocyte intercellular adhesion. J. Cell Biol. 1993; 120: 523-35.
19. Agrez MV, Bates RC, Mitchell D et al. Multiplicity of fibronectin-binding αv integrin receptors in colorectal cancer. Br. J. Cancer 1996; 73: 887-92.
20. Nigam AK, Savage FJ, Boulos PB, Stamp GWH, Liu D, Pignatelli M. Loss of cell-cell and cell-matrix adhesion in colorectal cancer. Br. J. Cancer 1993; 68: 507-14.
21. Breuss JM, Gillet N, Lu L, Sheppard D, Pytela R. Restricted distribution of integrin β6 mRNA in primate epithelial tissues. J. Histochem. Cytochem. 1993; 41: 1521-7.
22. Humphries M, Olden K, Yamada K. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986; 233: 467-70.
23. Gehlsen K, Argraves W, Pierschbacher M, Ruoslahti E. Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing peptides. J. Cell Biol. 1988; 106: 925-30.
24. Bresalier RS, Hujanen ES, Raper SE et al. An animal model for colon cancer metastasis: Establishment and characterization of murine cell lines with enhanced liver-metastasizing ability. Cancer Res. 1987; 47: 1398-1406.
25. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5.
26. Overduin M, Harvey TS, Bagby S et al. Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. Science 1995; 267: 386-9.
27. Nose A, Tsuji K, Takeichi M. Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 1990; 61: 147-55.
28. Nagafuchi A, Takeichi M. Transmemhrane control of cadherin-mediated cell adhesion: A 94kDa protein functionally associated with a specific region of the cytoplasmic domain of E-cadherin. Cell Regul. 1989; 1: 37-44.
29. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc. Natl. Acad. Sci. USA 1990; 87: 4246-50.
30. Peifer M. Cancer, catenins and cuticle pattern: A complex connection. Science 1993; 262: 1667-8.
31. Pignatelli M, Liu D, Nasim MM, Stamp GWH, Hirano S, Takeichi M. Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells. Br. J. Cancer 1992; 66: 629-34.
32. Robertson MJ, Soiffer RJ, Wolf SF et al. Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 1992; 175: 779-88.
33. Chan SH, Perussia B, Gupta JW et al. Induction of IFN-γ production by NK cell stimulatory factor (NKSF): Characterization of the responder cells and synergy with other inducers. J. Exp. Med. 1991; 173: 869-75.
34. Hiscox S, Hallett MB, Puntis MCA, Jiang WG. Inhibition of cancer cell motility and invasion by interleukin-12. Clin. Exp. Metastasis 1995; 13: 396-404.
35. Kinsella AR, Green B, Lepts GC, Hill CL, Bowie G, Taylor BA. The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br. J. Cancer 1993; 67: 904-9.
36. Dorudi S, Hanby AM, Poulsom R, Northover J, Hart IR. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br. J. Cancer 1995; 71: 614-16.
37. Rubinfeld B, Souza B, Albert I et al. Association of the APC gene product with β-catenin. Science 1993; 262: 1731-4.
38. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA 1995; 92: 3046-50.
39. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988; 319: 525-32.
40. Thompson JA, Zimmerman W, Osthus-Bugat P et al. Long-range chromosomal mapping of the carcinoembryonic antigen (CEA) gene family cluster. Genomics 1992; 12: 761-72.
41. Thompson JA, Grunert F, Zimmerman W. The carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J. Clin. Lab. Anal. 1991; 5: 344-66.
42. Hefta SA, Kefta LJF, Lee TD, Paxton RJ, Shively JE. Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: Identification of the ethanolamine linkage site. Proc. Natl. Acad. Sci. USA 1988; 85: 4648-52.
43. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J. Exp. Med. 1965; 122: 467-81.
44. Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989; 57: 327-34.
45. Pignatelli M, Durbin H, Bodmer WF. Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions. Proc. Natl. Acad. Sci. USA 1990; 87: 1541-5.
46. Levin LV, Griffin TW. Specific adhesion of Carcinoembryonic antigen-bearing colorectal cancer cells to immobilised carcinoembryonic antigen. Cancer Lett. 1991; 60: 143-52.
47. Kitsuki H, Katano M, Morisuki T, Torisu M. CEA-mediated homotypic aggregation of human colorectal carcinoma cells in a malignant effusion. Cancer Lett. 1995; 88: 7-13.
48. Majuri ML, Hakkarainen M, Paavonen T, Renkonen R. Carcinoembryonic antigen is expressed on endothelial cells. A putative mediator of tumor cell extravasation and metastasis. APMIS 1994; 102: 432-8.
49. Ishii S, Steele G Jr, Ford R et al. Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. Gastroenterology 1994; 106: 1242-50.
50. Takami N, Misumi Y, Kuroki M, Matsuoka Y, Ikehara Y. Evidence for carboxy-terminal processing and glycolipid anchoring of human carcinoembryonic antigen. J. Biol. Chem. 1988; 263: 12716-20.
51. Jothy S, Yuan S-Y, Shirota K. Transcription of carcinoembryonic antigen in normal colon and colon carcinoma. In situ hybridization study and implication for a new functional model. Am. J. Pathol. 1993; 143: 250-7.
52. Hosteller RB, Augustus LB, Mankarious R et al. Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis. J. Natl. Cancer Inst. 1990; 82: 380-5.
53. Moertel CG, O'Fallon JR, Go VL, O'Connell MJ, Thynne GS. The preoperative carcinoembryonic antigen test in the diagnosis, staging and prognosis of colorectal cancer. Cancer 1986; 58: 603-10.
54. Hinoda Y, Neumaier M, Hefta SA et al. Molecular cloning of a cDNA coding biliary glycoprotein I: Primary structure of a glycoprotein immunologically cross-reactive with carcinoembryonic antigen. Proc. Natl. Acad. Sci. USA 1988; 85: 6959-63.
55. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function-associated LFA-1,CD2, and LFA-3 molecules: Cell adhesion receptors of the immune system. Annu. Rev. Immunol. 1987; 5: 223-52.
56. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991; 65: 961-71.
57. Dippold W, Wittig B, Schwaeble W, Mayet W, Meyer zum Büschenfelde K-H. Expression of intercellular adhesion molecule 1 (ICAM-1, CD54) in colonic epithelial cells. Gut 1993; 34: 1593-7.
58. Johnson JP, Stade BG, Holzmann B, Schwaeble W, Riethmüller G. De novo expression of intercellular adhesion molecule-1 in melanoma correlates with increased risk of metastasis. Proc. Natl. Acad. Sci. USA 1989; 86: 641-4.
59. Kelly CP, Keates S, Siegenberg D, Linevsky JK, Pothoulakis C, Brady HR. IL-8 secretion and neutrophil activation by HT-29 colonic epithelial cells. Am. J. Physiol. 1994; 267: G991-7.
60. Ruoslahti E, Giancotti FG. Integrins and tumor cell dissemination. Cancer Cells 1989; 1: 119-26.
61. Zucker S, Lysik RM, Zarrabi MH, Moll U. M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 1993; 53: 140-6.
62. Raza S, Benyon RC, Arthur MJP, Lackie PM. Cleavage of the cell adhesion molecules CD44 and ICAM-1 by matrix metalloproteinases (Abstract). Mol. Biol. Cell 1995; 6: 165.
63. Koopman G, van Kooyk Y, de Graaff M, Meyer CJ, Figdor CG, Pals ST. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway. J. Immunol. 1990; 145: 3589-93.
64. Shimizu Y, van Seventer G, Siraganian R, Wahl L, Shaw S. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 1989; 143: 2457-63.
65. Aruffo AI, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990; 61: 1303-13.
66. Toyama-Sorimachi N, Sorimachi H, Tobita Y et al. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. J. Biol. Chem. 1995; 270: 7437-44.
67. Jalkanen S, Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 1992; 116: 817-25.
68. Wayner EA, Carter WG, Piotrowicz RS, Kunucki TJ. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: Preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J. Cell Biol. 1988; 107: 1881-91.
69. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 1992; 89: 12160-4.
70. Mulder J-WR, Wielenga VJM, Polak MM et al. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 1995; 36: 76-80.
71. Mulder J-WR, Kruyt PM, Sewnath M et al. Colorectal cancel-prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994; 344: 1470-1.
72. Günthert LJ, Hofmann M, Rudy W et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
73. Heider K-H, Hofmann M, Hors E et al. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol. 1993; 120: 227-33.
74. Tanabe KK, Stamenkovic I, Cutler M, Takahashi K. Restoration of CD44H expression in colon carcinomas reduces tumorigenicity. Ann. Surg. 1995; 222: 493-503.
75. Stamenkovic I, Aruffo A, Amiot M, Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 1991; 10: 343-8.
76. Rustigi AK. Biochemical and genetic screening of colorectal cancer. Gastroenterology 1995; 109: 1003-4.
77. Dutta SK, Silverstein RJ, Fleisher AS, Vengurlekar SM, Shami S, Nair PP. Increased expression of CD44 in isolated fecal colonocytes in patients with colonic neoplasia (Abstract). Gastrointest. Oncol. 1995; 108: A463.
78. Fukushima K, Hirota M, Terasaki PI et al. Characterization of sialosylated Lewis' as a new tumor-associated antigen. Cancer Res. 1984; 44: 5279-85.
79. Hanski C, Bornhoeft G, Topf N, Hermann U, Stein H, Riecken EO. Detection of a mucin marker for the adenoma-carcinoma sequence in human colonic mucosa by monoclonal antibody AM-3. J. Clin. Pathol. 1990; 43: 379-85.
80. Hanski C, Drechsler K, Hanisch FG et al. Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis' expression. Cancer Res. 1993; 53: 4082-8.
81. Hanski C, Hanski M-L, Zimmer T, Ogorek D, Devine P, Riecken EO. Characterization of the major sialyl-Le′-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer. Cancer Res. 1995; 55: 928-33.
82. Bevilacqua MP, Nelson LM. Selectins. J. Clin. Invest. 1993; 91: 379-87.
83. Takada A, Ohmori K, Yoneda T et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993; 53: 354-61.
84. Dawson PM, Habib NA, Fane S, Rees HC, Woods CB, Allen-Mersh TG. Association between extent of colonic mucosal sialomucin change and subsequent local recurrence after curative excision of primary colorectal cancer. Br. J. Surg. 1990; 77: 1279-83.